Application of this vaccine would allow manipulation of treatments in such a way that may induce a controlled and not sustained Abs response against IL-15 in diseases such as RA which are characterized by periods of crisis and remissions [49]. The gene discussed is IL15; the disease is rheumatoid arthritis.